Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 890.13M P/E - EPS this Y -16.20% Ern Qtrly Grth -
Income 55.8M Forward P/E 29.62 EPS next Y 25.80% 50D Avg Chg 18.00%
Sales 321.48M PEG 1.34 EPS past 5Y 31.85% 200D Avg Chg 76.00%
Dividend N/A Price/Book N/A EPS next 5Y 15.00% 52W High Chg -10.00%
Recommedations 2.00 Quick Ratio 2.95 Shares Outstanding 147.58M 52W Low Chg 217.00%
Insider Own 2.24% ROA 11.30% Shares Float 116.20M Beta 1.38
Inst Own 61.30% ROE 62.09% Shares Shorted/Prior 5.51M/5.52M Price 7.70
Gross Margin 83.01% Profit Margin 18.11% Avg. Volume 878,906 Target Price 12.50
Oper. Margin 17.84% Earnings Date Apr 30 Volume 1,510,585 Change -2.90%
About MiMedx Group, Inc

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was incorporated in 2011 and is headquartered in Marietta, Georgia.

MiMedx Group, Inc News
04/16/24 MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
04/11/24 MDXG: Legal Avenues
07:00 AM MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
03/21/24 Investing in MiMedx Group (NASDAQ:MDXG) a year ago would have delivered you a 138% gain
03/20/24 MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
03/13/24 MIMEDX Introduces E-Commerce and Account Management Platform
03/04/24 MIMEDX Announces Appointment of Two New Independent Directors
03/01/24 MiMedx Group, Inc.'s (NASDAQ:MDXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
03/01/24 MiMedx Group Full Year 2023 Earnings: EPS Beats Expectations
02/29/24 MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2023 Earnings Call Transcript
02/29/24 MDXG: Another Beat & Raise
02/28/24 MiMedx Group Inc (MDXG) Reports Strong Year-Over-Year Sales Growth and Net Income Surge in Q4 ...
02/28/24 MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
02/21/24 MiMedx Group Inc Insider Sells Shares
02/20/24 MIMEDX to Present at TD Cowen 44th Annual Health Care Conference
02/13/24 Get Rich Quick With These 3 Biotech Stocks to Buy Now
02/12/24 MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28
01/22/24 MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing
01/15/24 Owning 49% shares,institutional owners seem interested in MiMedx Group, Inc. (NASDAQ:MDXG),
01/03/24 MDXG: Axiofill Update & Series B Conversion
MDXG Chatroom

User Image GlobalInsights Posted - 15 hours ago

$MDXG For the LCD announcement where does one find the covered list!

User Image Windy007 Posted - 22 hours ago

$MDXG

User Image SnapCrackleStop Posted - 23 hours ago

$MDXG Company could have and still can securitize AmnioFix as a Bio Pharma/Regenerative pure play and spin it off to shareholders as a separate entity a Regenerative Med Co. They could get investment banking financing through a secondary and let the drug proceed onto trails PH II & III. The injectable works. It’s proven. Just need the expensive trials to prove it and get IND/ BLA. I’m sure if they tried they could do this still & attract bio spec capital to the spinoff venture. Potential future value is Big. How big? $$$

User Image Monticello4 Posted - 1 day ago

$MDXG Every damn day, early in the day, the stock gets hammered at the opening and then again betweem 9:50 and 11am ...

User Image str8bite Posted - 1 day ago

$MDXG Great for Capper and Marty to remove Biopharma/Amniofix from the company, emphatically state this is only a medtech company......only to continue having biopharma board members and COB........Capper and Marty way to go!

User Image SnapCrackleStop Posted - 1 day ago

$MDXG Thank you BOD and C-Suite for making yourselves millionaires at the expense of shareholders. You deserve all the free shares you can grant yourselves. NOT $$$

User Image biomaster22 Posted - 1 day ago

$MDXG wonderful earning next week and with news were in low $6's thanks Crapper !

User Image WaltherWilliam Posted - 1 day ago

$MDXG these boobs are gonna work us over. They’ll make their money. But, sir, can we make ours? The stuff works. Thank you, Sir!!!

User Image WaltherWilliam Posted - 1 day ago

$MDXG how’d it drop today? Strange. And then right back up. SEC are on the job. All good. Are we all brain dead sucks? This was a fix. A play. But, end state says they would kill it or scare us off. I ain’t scairt

User Image Mouton_Noir Posted - 1 day ago

$MDXG Am I reading the proposed LCD info wrong? This is joint effort of all MACs banding together to basically eliminate all skin subs w/out strong clinical evidence. Epifix and Epicord made the cut (Epieffect did not, due to no published data). Most of ORGOs portfolio did not - including Puraply. This is why their stock tanked 23% today. There's only handful of eligible products left. WAY less than what the 3 MACs proposed last summer. They limited # of applications to 4 again, but this time and unlike last summers proposal they are allowing exceptions for patients who need higher number of grafts. Need more time to digest this... but I don't know how this cannot be viewed as a win?

User Image Windy007 Posted - 1 day ago

$MDXG Go here and hit the link within. This looks like positive news for MDXG and it would take away coverage from many competitor’s products including ORGO https://www.cms.gov/newsroom/press-releases/cms-statement-proposed-local-coverage-determination-lcd-skin-substitute-grafts/cellular-and-tissue

User Image GlobalInsights Posted - 1 day ago

$MDXG Decent recovery on big volume, ORGO didn’t do so well!

User Image microdude Posted - 1 day ago

$MDXG https://www.cms.gov/newsroom/press-releases/cms-statement-proposed-local-coverage-determination-lcd-skin-substitute-grafts/cellular-and-tissue

User Image microdude Posted - 2 days ago

$ORGO $MDXG ORGO filled waiting on MDXG.

User Image KnowWhatsRight Posted - 2 days ago

$MDXG Well I was wrong...MDXG did trade below $6..but only for 1 hr before Joe Capper and a couple of BoD members bought 250k shares...I do think that we will see $8 next week. Thanks for listening to advice Joe !

User Image Monticello4 Posted - 2 days ago

$MDXG

User Image microdude Posted - 2 days ago

$MDXG ORGO too

User Image microdude Posted - 2 days ago

$MDXG looks like chicken man is out trashing MDXG again. Created great buying opportunity last time. Have to revisit.

User Image weichsel1 Posted - 2 days ago

$MDXG down 30% in a month with no real news.. remember that after the FDA announcements sales projections were still confirmed

User Image SnapCrackleStop Posted - 2 days ago

$MDXG Gotta love Nasdaq. $ORGO down 15%. $MDXG down 11%. Nothing changed since yesterday for both Companies. Sheeeeez! $$

User Image SnapCrackleStop Posted - 2 days ago

$MDXG Tanked … before earnings!!! Lots of shares for sale…. Not looking good for the home team. $$

User Image GlobalInsights Posted - 2 days ago

$MDXG Way to go Joe, your screwing up this company just like the last 2 CEO’s. But your no worried because you get millions no matter what the outcome.

User Image ta99bobotw Posted - 2 days ago

$MDXG what's going on? Is there any news?

User Image Monticello4 Posted - 2 days ago

$MDXG Short Interest up 331,000+ shares

User Image KnowWhatsRight Posted - 2 days ago

$MDXG Capper knows that he needs tro get a couple of money center banks, BioTech analysts to start covering MDXG. So...along with a strong earnings report, Capper (and some BoD members) must BUY some stock. Just waiting to collect "the paper" at Bonus time every year does not impress big time analysts. BUY some stock Mr Capper. You heard me,

User Image SnapCrackleStop Posted - 3 days ago

$MDXG My folks tell me the earnings report will be stellar. We shall see next week I suppose… $$

User Image KnowWhatsRight Posted - 3 days ago

$MDXG We will see 8 before we ever see 6 after earnings. Could be higher if Capper has positive news regarding suit vs FDA. call.

User Image Raiderdave98 Posted - 4 days ago

$MDXG only two 5% holders. Due to 20% dilution? Or did they sell.

User Image str8bite Posted - 4 days ago

$MDXG Crossed above 8dema, small step in right direction. Next resistance $6.54 and $6.80 is the big one. So hard to repair a broken chart.

User Image SnapCrackleStop Posted - 4 days ago

$MDXG It’s virtual annual meeting time again folks!!! These execs don’t want to meet you. They are scared what a real in person shareholder meeting would be like. Hide! Yea go ahead you bunch of lazy greedy “take whatever you can steal” leaders. This BOD doesn’t get my vote. $

Analyst Ratings
Lake Street Buy Mar 7, 24
Mizuho Buy Mar 1, 24
Mizuho Buy Oct 31, 23
Craig-Hallum Buy Oct 27, 23
Mizuho Buy Aug 2, 23
HC Wainwright & Co. Buy Aug 2, 23
HC Wainwright & Co. Buy Jun 21, 23
HC Wainwright & Co. Buy May 3, 23
HC Wainwright & Co. Buy Mar 2, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Capper Joseph H Chief Executive Offi.. Chief Executive Officer Jun 22 Buy 6.42 100,000 642,000 100,000 06/26/23
Stein Robert Benjamin President, Regenerat.. President, Regenerative Med. May 15 Sell 6.05 13,972 84,531 317,803 05/17/23
Hulse William Frank IV General Counsel and.. General Counsel and CAO May 10 Sell 5.9261 5,870 34,786 456,564 05/12/23
Stein Robert Benjamin President, Regenerat.. President, Regenerative Med. May 10 Sell 5.9261 5,869 34,780 331,775 05/12/23
Phelan William Lawrence Chief Accounting Off.. Chief Accounting Officer May 10 Sell 5.9261 1,595 9,452 184,219 05/12/23
Carlson Peter M Chief Financial Offi.. Chief Financial Officer May 10 Sell 5.9261 5,976 35,414 656,435 05/12/23
Stein Robert Benjamin President, Regenerat.. President, Regenerative Med. May 04 Sell 5.3418 51,756 276,470 337,644 05/09/23
Phelan William Lawrence Chief Accounting Off.. Chief Accounting Officer May 02 Sell 3.796 5,200 19,739 185,814 05/03/23
Phelan William Lawrence Chief Accounting Off.. Chief Accounting Officer Apr 25 Sell 3.744 1,628 6,095 191,014 04/27/23
Stein Robert Benjamin President, Regenerat.. President, Regenerative Med. Apr 25 Sell 3.744 5,987 22,415 389,400 04/27/23
Hulse William Frank IV General Counsel and.. General Counsel and CAO Apr 25 Sell 3.744 5,988 22,419 462,434 04/27/23
Carlson Peter M Chief Financial Offi.. Chief Financial Officer Apr 25 Sell 3.744 6,094 22,816 662,411 04/27/23
Phelan William Lawrence Chief Accounting Off.. Chief Accounting Officer Apr 11 Sell 3.31 1,632 5,402 192,642 04/13/23
Stein Robert Benjamin President, Regenerat.. President, Regenerative Med. Apr 11 Sell 3.31 5,996 19,847 395,387 04/13/23
Hulse William Frank IV General Counsel and.. General Counsel and CAO Apr 11 Sell 3.31 5,995 19,843 468,422 04/13/23
Carlson Peter M Chief Financial Offi.. Chief Financial Officer Apr 11 Sell 3.31 6,100 20,191 668,505 04/13/23
Stein Robert Benjamin President, Regenerat.. President, Regenerative Med. Mar 07 Sell 4.2446 12,355 52,442 266,318 03/09/23
Phelan William Lawrence Chief Accounting Off.. Chief Accounting Officer Mar 07 Sell 4.2446 3,396 14,415 141,244 03/09/23
Carlson Peter M Chief Financial Offi.. Chief Financial Officer Mar 07 Sell 4.2446 12,056 51,173 534,150 03/09/23
Hulse William Frank IV General Counsel and.. General Counsel and CAO Mar 07 Sell 4.2446 11,308 47,998 338,053 03/09/23
Carlson Peter M Chief Financial Offi.. Chief Financial Officer Dec 22 Sell 2.8151 4,992 14,053 565,206 12/27/22
Stein Robert Benjamin President, Regenerat.. President, Regenerative Med. Sep 12 Sell 3.45 27,329 94,285 278,673 09/14/22
Stein Robert Benjamin President, Regenerat.. President, Regenerative Med. Aug 12 Sell 4.039 8,503 34,344 306,002 08/16/22
Kashyap Rohit President, WC & Surg.. President, WC & Surgical Aug 09 Sell 4.208 12,343 51,939 430,072 08/11/22
Stein Robert Benjamin President, Regenerat.. President, Regenerative Med. Aug 04 Sell 3.62 19,500 70,590 314,505 08/08/22
Stein Robert Benjamin President, Regenerat.. President, Regenerative Med. Jun 28 Sell 3.47 14,600 50,662 334,005 06/30/22
WRIGHT TIMOTHY R Chief Executive Offi.. Chief Executive Officer Jun 09 Sell 3.75 112,000 420,000 1,711,324 06/13/22
WRIGHT TIMOTHY R Chief Executive Offi.. Chief Executive Officer Feb 23 Sell 4.3127 61,000 263,075 1,266,256 02/25/22
Turner Scott M SVP, Operations & Pr.. SVP, Operations & Procurement Feb 23 Sell 4.50 5,738 25,821 174,586 02/25/22
Hulse William Frank IV General Counsel General Counsel Feb 23 Sell 4.41 13,500 59,535 196,335 02/25/22